High Methylmalonic Acid Symptoms: Causes, Signs & What to Do
Elevated methylmalonic acid (MMA) is the most sensitive functional marker of vitamin B12 deficiency -- it rises before serum B12 falls below the reference range and before neurological damage becomes obvious. This page covers the specific symptoms, likely causes, normal ranges, and when to act.
Methylmalonic acid (MMA) is an intermediate in the metabolism of certain amino acids and odd-chain fatty acids. The enzyme that converts methylmalonyl-CoA to succinyl-CoA requires adenosylcobalamin — the active mitochondrial form of vitamin B12. When B12 is functionally deficient, this conversion step fails and MMA accumulates in blood and urine. High MMA is more sensitive than serum B12 for detecting functional B12 deficiency: serum B12 can appear normal (in the 200-400 pg/mL range) while MMA is already elevated, indicating that B12 is not available in sufficient active form to support cellular metabolism. See the Methylmalonic Acid biomarker overview for how MMA is measured and what normalized values mean.
What High Methylmalonic Acid Means
Elevated MMA (above 270-400 nmol/L serum, or above 3.6 µmol/mmol creatinine in urine depending on the assay) indicates one of three situations:
- Functional vitamin B12 deficiency — the most common cause in adults; B12 is the rate-limiting cofactor; even “low-normal” serum B12 levels can be associated with elevated MMA and B12-related neurological symptoms
- Chronic kidney disease — MMA is cleared by the kidneys; reduced GFR causes MMA to accumulate without true B12 deficiency; always interpret MMA alongside eGFR
- Hereditary methylmalonic acidemia — rare inborn error of metabolism presenting in infancy with catastrophically high MMA levels (millimolar range); not the cause of mildly elevated MMA in adults
MMA is particularly useful in three clinical situations: (a) diagnosing B12 deficiency when serum B12 is in the borderline range, (b) detecting early subclinical B12 deficiency before macrocytosis or neurological symptoms develop, and (c) monitoring B12 therapy response (MMA should normalize within 4-8 weeks of adequate B12 replacement).
Symptoms of High Methylmalonic Acid
Elevated MMA reflects underlying B12 deficiency — the symptoms are those of B12 deficiency, not of MMA accumulation itself.
Neurological symptoms (the most clinically significant):
- Peripheral neuropathy — symmetrical numbness, tingling, and burning in the feet and hands (stocking-glove distribution); typically ascending
- Subacute combined degeneration of the spinal cord — posterior column damage causing proprioception loss, positive Romberg sign, broad-based unsteady gait; lateral column involvement causes spasticity and Babinski sign; this syndrome can be irreversible if untreated
- Cognitive changes — memory difficulties, slowed processing, mood disturbances, concentration problems; “megaloblastic madness” in severe cases
- Optic neuropathy — painless, progressive visual loss from optic nerve involvement; rare but well-documented
Hematologic symptoms (from megaloblastic anemia — may be absent if B12 is only mildly deficient):
- Fatigue and weakness
- Shortness of breath on exertion
- Pallor
- Lemon-yellow tint to skin (from concurrent hemolysis raising bilirubin)
Other B12-specific findings:
- Glossitis — sore, smooth, pale tongue; loss of papillae
- Angular cheilitis — cracking at the corners of the mouth
What Causes High Methylmalonic Acid
Vitamin B12 deficiency (most common cause):
- Pernicious anemia — autoimmune gastritis destroying parietal cells; loss of intrinsic factor blocks B12 absorption; anti-parietal cell antibodies and anti-intrinsic factor antibodies confirm; the leading cause in older adults
- Dietary deficiency — strict vegan or vegetarian diet without B12 supplementation; B12 is found only in animal products (meat, fish, dairy, eggs); takes years to deplete stores but MMA rises before stores are fully depleted
- Metformin use — reduces ileal B12 absorption by approximately 30% over years; increasingly common cause of functional B12 deficiency in type 2 diabetes
- Proton pump inhibitors (PPIs) — reduce gastric acid needed to cleave protein-bound B12 from food; MMA may rise with long-term PPI use
- Gastric bypass or sleeve gastrectomy — removes the portion of the stomach producing intrinsic factor and stomach acid; B12 supplementation is mandatory post-procedure
- Terminal ileum disease — Crohn’s disease affecting the ileum (the only site of B12 absorption); resection or inflammation blocks intrinsic factor-B12 complex absorption
- Chronic atrophic gastritis (H. pylori-related) — reduces intrinsic factor production before pernicious anemia develops
Chronic kidney disease:
- MMA accumulates with reduced GFR; MMA above 400 nmol/L in the context of eGFR below 45 mL/min/1.73m² may reflect CKD rather than B12 deficiency; homocysteine is also elevated in CKD, complicating interpretation
Normal Methylmalonic Acid Levels
| Category | Serum MMA (nmol/L) | |---|---| | Normal | 70-270 nmol/L | | Borderline elevated (B12 deficiency possible) | 270-400 nmol/L | | Elevated (B12 deficiency likely, or CKD) | Above 400 nmol/L |
Values vary by laboratory and assay; always use your lab’s reference range. Urine MMA is also used and normalized to creatinine (reference typically below 3.6 µmol/mmol creatinine).
When to See Your Care Team
Book a 1:1 consultation with a licensed care team lead for MMA above the lab’s reference range, particularly with any neurological symptoms (numbness, balance problems, cognitive changes). The essential concurrent tests are serum B12, homocysteine, eGFR, and CBC. If B12 deficiency is confirmed, the cause must be identified — pernicious anemia requires lifelong intramuscular B12 (because oral absorption depends on intact intrinsic factor); dietary deficiency can be managed with high-dose oral B12 or intramuscular therapy; drug-induced deficiency requires supplementation.
Frequently Asked Questions
Why is MMA more useful than serum B12 alone?
Serum B12 measures total circulating B12, including inactive forms (haptocorrin-bound B12 from transcobalamin I, which cannot enter cells). A serum B12 in the 200-400 pg/mL range may be adequate for some people and frankly deficient for others. MMA is a functional downstream measure: it only rises when there is genuinely insufficient adenosylcobalamin available to run the methylmalonyl-CoA mutase reaction. Elevated MMA with borderline B12 is the clearest indication of functionally significant deficiency.
How quickly does MMA normalize with B12 treatment?
MMA typically normalizes within 4-8 weeks of adequate B12 replacement (intramuscular injections or high-dose oral B12, usually 1,000 µg daily). Neurological symptoms improve over months but may not fully resolve depending on the duration of deficiency before treatment. Hematologic response (reticulocytosis, hemoglobin improvement) begins within 1-2 weeks. Failure of MMA to normalize after 8 weeks of adequate B12 therapy suggests CKD is contributing to the elevation.
Can I have high MMA with a normal B12 level?
Yes — this is the key clinical insight. MMA is elevated in approximately 25-40% of people with serum B12 in the “borderline normal” range (200-400 pg/mL). This pattern — high MMA + borderline B12 — represents functional deficiency where serum B12 is insufficient to fully meet cellular demand even though it has not yet fallen below the laboratory’s lower reference limit. Neurological symptoms with this pattern are a strong indication for B12 supplementation regardless of whether B12 is technically “normal” on the report.
Is methylmalonic acid different from homocysteine as a B12 marker?
Both MMA and homocysteine rise in B12 deficiency. However, homocysteine also rises in folate deficiency, hypothyroidism, CKD, and with certain medications — it is less specific for B12 deficiency alone. MMA rises specifically when the B12-dependent methylmalonyl-CoA mutase is impaired (not in isolated folate deficiency). Together, elevated MMA + elevated homocysteine strongly points to B12 deficiency; elevated homocysteine with normal MMA suggests folate deficiency or another cause.
